A panel of immunization experts has voted to expand the recommendation for the nasal spray influenza vaccine, FluMist (MedImmune Vaccines, Inc., Gaithersburg, Md.), to include healthy children from 2 to 5 years of age who are healthy and don't have a history of asthma or wheezing. [click link for full article]
(more...)